Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absorption, Andrew, ascertain, assay, attack, BIOb, Canada, cited, Citibank, comparison, cyber, cyberattack, Daskal, degrade, disable, dispute, earliest, endorsed, escrow, Exact, geopolitical, heavily, Hertia, Ilan, implicit, inception, incident, innovation, John, Joint, layered, led, LLC, membership, Mexican, Mexico, misuse, MUFG, noncancellable, offline, online, outbreak, predominantly, Proforma, PST, ransom, rare, receipt, reissued, reissuing, repayment, repurposed, ROU, sabotage, SAP, Satisfaction, Simplification, uncommon, unrelated, verification
Removed:
accelerated, acid, actively, agreed, antibody, bearing, biopsy, cancer, check, Christine, combined, continuing, cooperation, decreasing, deduction, delinquent, deposit, disgorgement, eliminated, employer, enabling, entity, exceeded, excise, expired, expression, filer, forfeiture, foundational, gene, genetic, genomic, GnuBIO, implemented, implied, improving, informed, inherited, investigate, Latin, mark, marketability, monitoring, moratorium, par, phase, preceding, preferred, priced, Pub, RainDance, reclassify, reversal, revised, scope, seasoned, sequencing, shell, spend, step, submitted, terminal, traded, updated, virtue, Washington
Filing tables
Filing exhibits
- 10-K Annual report
- 4.1 Exhibit 4.1 12.31.19
- 21.1 Exhibit 21.1 12.31.19
- 23.1 Exhibit 23.1 12.31.19
- 31.1 Exhibit 31.1 CEO Section 302 Certification
- 31.2 Exhibit 31.2 CFO Section 302 Certification
- 32.1 Exhibit 32.1 CEO Section 906 Certification
- 32.2 Exhibit 32.2 CFO Section 906 Certification
- Download Excel data file
- View Excel data file
Related press release
Associated BIO transcripts
BIO similar filings
Filing view
External links
Exhibit 32.2
Certification of Periodic Report
I, Ilan Daskal, Chief Financial Officer of Bio-Rad Laboratories, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:
(1) | the Annual Report on Form 10-K of the Company for the year ended December 31, 2019 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: | February 28, 2020 | /s/ Ilan Daskal | |
Ilan Daskal, Executive Vice President, | |||
Chief Financial Officer |
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Annual Report or as a separate disclosure document.